Title : In vitro assessment of the potential for dolutegravir to affect hepatic clearance of levonorgestrel.

Pub. Date : 2021 Nov

PMID : 34328253






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Unbound dolutegravir >= 431 nM induced expression of CYP3A4 (>= two-fold) in a dose-dependent manner, while 1.44 muM of unbound dolutegravir induced CYP2B6 expression 2.2 +- 0.3-fold (P = 0.0004). dolutegravir cytochrome P450 family 2 subfamily B member 6 Homo sapiens
2 Unbound dolutegravir >= 431 nM induced expression of CYP3A4 (>= two-fold) in a dose-dependent manner, while 1.44 muM of unbound dolutegravir induced CYP2B6 expression 2.2 +- 0.3-fold (P = 0.0004). dolutegravir cytochrome P450 family 2 subfamily B member 6 Homo sapiens